▷ Cotización de INBX Noticias y Datos Financieros de Inhibrx Inc

ESCÁNER DE ACCIONES AMERICANAS DE TRADINGCERO.COM (VERSIÓN 1.0) Hora Nueva York:
(2022-07-04)Formato Y-M-D

EARNINGS AYER: Ayer no hubo informes de resultados.
EARNINGS HOY: No hay informes de resultados previstos para hoy.
EARNINGS MAÑANA: No hay informes de resultados previstos para mañana.

IPOS AYER: Ayer no hubo IPOS.
IPOS HOY: No hay IPOS previstas para hoy.
IPOS MAÑANA: No hay IPOS previstas para mañana.

[ Escáners ]  1. Escáner de TODAS las Acciones.
  2. Escáner de PennyStocks (<= $10).
  3. Escáner de SmallCaps ($10 < y <= $80).
  4. Escáner de LargeCaps ( > $80).

[ Screener ]  >> Screener de TradingCero.com

[ Calendario de Earnings ]  >> Empresas que publicarán sus Informes de Resultados próximamente

[ Calendario de IPOS ]  >> Empresas que debutarán en WallStreet próximamente

[ Industrias / Sectores ]  >> Listado de Insdustrias y Sectores en WallStreet

[ Panel Predictivo ]  >> Acceso restringido

[ Descarga de Informes ]  >> Acceso restringido

[ Registro de Cambios ]  >> Registro de Cambios en el Escáner.

[ PÁGINA ACTUALIZADA EL 2022-07-04 23:19:44 hrs (New York) ]

Nombre:Nombre de la Empresa, Número de Empleados y web si está disponible	Inhibrx Inc Empleados: 88 Web Disponible
Industria:Industria a la que pertenece la Empresa	Biological Product except Diagnostic Manufacturing
Sector:Sector al que pertenece la Empresa	Manufacturing
Market Cap.:Capitalización de Mercado de la Empresa	426.42 M
Insider Own:Porcentaje de Acciones que poseen los Socios de la Empresa	31.57 %
Shares:Número total de Acciones de la Empresa	39.02 M
Float:Flotante (Acciones disponibles para comprar/vender) de la Empresa	26.71 M
Short Float:Porcentaje de Acciones en Corto de los Inversores sobre la Empresa	12.27 %
Volumen:Volumen de operaciones de la última sesión de mercado sobre la Empresa	0.24 M
Vol. Medio:Volumen Medio Diario de operaciones realizadas en el Mercado sobre la Empresa	0.44767 M
Último %:Cambio en porcentaje: Diario, Semanal, Mensual y Anual de la Empresa	2 % Semanal %: 0.62 % Mensual %: -13.16 % Anual %: 1 %

TODAS LAS NOTICIAS DE [ INBX ]

FECHA / HORA		ÚLTIMAS NOTICIAS
2022-06-30 09:00:00		>> Inhibrx Announces Completion of Phase 1 Combination Dose Escalation for INBRX 105 a Novel Targeted 4 1BB Agonist and Draws an Additional 60 Million ...Inhibrx Announces Completion of Phase 1 Combination Dose Escalation for INBRX 105 a Novel Targeted 4 1BB Agonist and Draws an Additional 60 Million from Oxford Finance
2022-05-19 16:05:00		>> Inhibrx Announces Details of Presentation at 2022 ASCO Annual Meeting ...Inhibrx Announces Details of Presentation at 2022 ASCO Annual Meeting
2022-05-16 12:32:00		>> Inhibrx s INBRX 101 Shows Favorable Safety Profile In An Inherited Disorder ...Inhibrx s INBRX 101 Shows Favorable Safety Profile In An Inherited Disorder
2022-05-16 09:00:00		>> INBRX 101 Shows Favorable Safety Profile in Patients with Alpha 1 Antitrypsin Deficiency and Demonstrates Potential to Achieve Normal Functional Alpha ...INBRX 101 Shows Favorable Safety Profile in Patients with Alpha 1 Antitrypsin Deficiency and Demonstrates Potential to Achieve Normal Functional Alpha 1 Antitrypsin Levels with Monthly Dosing
2022-05-09 18:35:00		>> Inhibrx Inc INBX Reports Q1 Loss Misses Revenue Estimates ...Inhibrx Inc INBX Reports Q1 Loss Misses Revenue Estimates
2022-05-09 17:25:00		>> Cara Therapeutics CARA Reports Q1 Loss Lags Revenue Estimates ...Cara Therapeutics CARA Reports Q1 Loss Lags Revenue Estimates
2022-05-09 16:05:00		>> Inhibrx Reports First Quarter 2022 Financial Results and Recent Corporate Highlights ...Inhibrx Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
2022-05-05 17:15:00		>> KaloBios Pharmaceuticals Inc HGEN Reports Q1 Loss Misses Revenue Estimates ...KaloBios Pharmaceuticals Inc HGEN Reports Q1 Loss Misses Revenue Estimates
2022-05-05 06:18:00		>> The 17 return this week takes Inhibrx s NASDAQ INBX shareholders one year gains to 25 ...The 17 return this week takes Inhibrx s NASDAQ INBX shareholders one year gains to 25
2022-05-03 06:32:00		>> Inhibrx Inc INBX Soars 15 Is Further Upside Left in the Stock ...Inhibrx Inc INBX Soars 15 Is Further Upside Left in the Stock
2022-04-25 09:00:00		>> Inhibrx Announces Formation of Scientific Advisory Board for INBRX 101 ...Inhibrx Announces Formation of Scientific Advisory Board for INBRX 101
2022-04-05 16:30:00		>> Inhibrx to Present INBRX 101 Data at ATS 2022 Annual Meeting ...Inhibrx to Present INBRX 101 Data at ATS 2022 Annual Meeting
2022-03-24 16:05:00		>> Inhibrx Announces Details of Presentations at 2022 AACR Annual Meeting ...Inhibrx Announces Details of Presentations at 2022 AACR Annual Meeting
2022-03-03 09:15:00		>> Inhibrx Receives FDA Orphan Drug Designation for INBRX 101 for the Treatment of Alpha 1 Antitrypsin Deficiency ...Inhibrx Receives FDA Orphan Drug Designation for INBRX 101 for the Treatment of Alpha 1 Antitrypsin Deficiency
2022-02-28 16:05:00		>> Inhibrx Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Recent Corporate Highlights ...Inhibrx Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Recent Corporate Highlights
2022-02-22 09:00:00		>> Inhibrx Announces Amended Loan Agreement with Oxford ...Inhibrx Announces Amended Loan Agreement with Oxford
2022-01-05 07:46:00		>> Inhibrx Shares Interim Data On INBRX 106 Keytruda Combo Therapy In Solid Tumors ...Inhibrx Shares Interim Data On INBRX 106 Keytruda Combo Therapy In Solid Tumors
2022-01-04 16:05:00		>> Inhibrx Announces Initial Phase 1 Dose Escalation Results for INBRX 106 a Novel Hexavalent OX40 Agonist in Combination with Keytruda Pembrolizuma ...Inhibrx Announces Initial Phase 1 Dose Escalation Results for INBRX 106 a Novel Hexavalent OX40 Agonist in Combination with Keytruda Pembrolizumab Along with Updated Single Agent Data
2021-12-20 08:50:00		>> Here s What Could Help Inhibrx Inc INBX Maintain Its Recent Price Strength ...Here s What Could Help Inhibrx Inc INBX Maintain Its Recent Price Strength
2021-12-01 16:05:00		>> Inhibrx Receives FDA Orphan Drug Designation for INBRX 109 in Chondrosarcoma ...Inhibrx Receives FDA Orphan Drug Designation for INBRX 109 in Chondrosarcoma
2021-11-25 09:08:00		>> Takeda TAK CMV Infection Drug Livtencity Gets FDA Approval ...Takeda TAK CMV Infection Drug Livtencity Gets FDA Approval
2021-11-24 10:31:00		>> Amryt AMYT Skin Disorder NDA Review Gets 3 Months Extension ...Amryt AMYT Skin Disorder NDA Review Gets 3 Months Extension
2021-11-23 10:00:00		>> Wall Street Analysts Predict a 32 Upside in Inhibrx Inc INBX Here s What You Should Know ...Wall Street Analysts Predict a 32 Upside in Inhibrx Inc INBX Here s What You Should Know
2021-11-10 07:47:00		>> Inhibrx NASDAQ INBX pulls back 3 4 this week but still delivers shareholders impressive 139 return over 1 year ...Inhibrx NASDAQ INBX pulls back 3 4 this week but still delivers shareholders impressive 139 return over 1 year

TODOS LOS TWEETS [ INBX ]

HORA	USUARIO	TWEET
2022-07-01 14:04:09	LUKIITASP	inbx nasdaq stock rating changed to hold inhibrx incticker is 237 off the historical support price ...inbx nasdaq stock rating changed to hold inhibrx incticker is 237 off the historical support price
2022-06-30 09:21:06	CHARTMILL	inbx is expected to show a strong revenue growth of 10033 yearly ...inbx is expected to show a strong revenue growth of 10033 yearly
2022-06-21 13:50:40	LUKIITASP	inbx nasdaq stock rating changed to hold inhibrx incticker is 1896 off the historical support price ...inbx nasdaq stock rating changed to hold inhibrx incticker is 1896 off the historical support price
2022-06-17 13:19:55	LUKIITASP	inbx nasdaq stock rating changed to hold inhibrx incticker is 1841 off the historical support price ...inbx nasdaq stock rating changed to hold inhibrx incticker is 1841 off the historical support price
2022-06-15 12:24:22	MONSTER2000	inbx nasdaq stock rating changed to hold inhibrx inc currently 1779 off the historical support price ...inbx nasdaq stock rating changed to hold inhibrx inc currently 1779 off the historical support price
2022-06-14 11:02:32	EBONIEHUHN	inbx nasdaq stock rating changed to buy inhibrx incticker is 205 off the historical support price ...inbx nasdaq stock rating changed to buy inhibrx incticker is 205 off the historical support price
2022-06-10 14:41:03	STOCK RESEARCH BOT	inhibrx incs quarterly revenue growth rate yoy of 290 ranked 2901 out of 5718 companies in our database ...inhibrx incs quarterly revenue growth rate yoy of 290 ranked 2901 out of 5718 companies in our database
2022-06-06 13:02:06	PRICETARGET.IO	inbx price target update reiterated by jmp securitiesprice target 40day quotechange 1088 529ta ... inbx price target update reiterated by jmp securitiesprice target 40day quotechange 1088 529ta
2022-06-06 10:21:10	JOE GAMBISTE	rt trdmktcrypto stock scalping 4htime 20220606 135620short inbx at 1147tp 110112sl 116994 inbx inbxjoin disco ...rt trdmktcrypto stock scalping 4htime 20220606 135620short inbx at 1147tp 110112sl 116994 inbx inbxjoin disco
2022-06-06 09:56:20	TRADINGMARKETCRYPTO	stock scalping 4htime 20220606 135620short inbx at 1147tp 110112sl 116994 inbx inbxjoin ...stock scalping 4htime 20220606 135620short inbx at 1147tp 110112sl 116994 inbx inbxjoin
2022-05-26 15:18:02	CHARTMILL	inbx was analyzed by 12 analysts the buy consensus is at 83 so analysts seem to be very confident about inbx ...inbx was analyzed by 12 analysts the buy consensus is at 83 so analysts seem to be very confident about inbx
2022-05-18 11:13:03	STOCK RESEARCH BOT	inhibrx incs quarterly revenue growth rate yoy of 450 ranked 2728 out of 5731 companies in our database ...inhibrx incs quarterly revenue growth rate yoy of 450 ranked 2728 out of 5731 companies in our database
2022-05-16 15:33:04	CHAMELEON	inbx stock declines 161 view latest news ...inbx stock declines 161 view latest news
2022-05-16 11:28:33	CHAMELEON	top stock gainers gff you carv rtlr prax top stock decliners tblt net mara inbx airs ...top stock gainers gff you carv rtlr prax top stock decliners tblt net mara inbx airs
2022-05-16 11:01:00	MEHABE	inbx 1522 986 inhibrx stock falls despite inbrx101 showing safety in earlystage study in genetic disea ...inbx 1522 986 inhibrx stock falls despite inbrx101 showing safety in earlystage study in genetic disea
2022-05-16 10:59:11	BREAKING NEWS	inbx inhibrx stock falls despite inbrx101 showing safety in earlystage study in genetic disease ...inbx inhibrx stock falls despite inbrx101 showing safety in earlystage study in genetic disease
2022-05-13 16:04:33	VERTICALL TRADING	vwap crossover ... vwap crossover
2022-05-13 13:45:54	EAGLE INVESTOR	inbx for a limited time we are opening our trading chatroom for public ...inbx for a limited time we are opening our trading chatroom for public
2022-05-13 09:54:13	TRADINGMARKETCRYPTO	stock scalping 4htime 20220513 135413short inbx at 16280001tp 15628801sl 16605601 inbx ...stock scalping 4htime 20220513 135413short inbx at 16280001tp 15628801sl 16605601 inbx
2022-05-13 07:23:01	CHARTMILL	inbx was analyzed by 12 analysts the buy consensus is at 83 so analysts seem to be very confident about inbx ...inbx was analyzed by 12 analysts the buy consensus is at 83 so analysts seem to be very confident about inbx
2022-05-11 10:13:05	CHARTMILL	a quick ratio of 620 indicates that inbx has no problem at all paying its short term obligations ...a quick ratio of 620 indicates that inbx has no problem at all paying its short term obligations
2022-05-03 08:24:33	BEEKEN HEALTHCARE	inbx inhibrx inc inbx soars 15 is further upside left in the stock ...inbx inhibrx inc inbx soars 15 is further upside left in the stock
2022-05-03 08:04:05	SHOGUNTRADE	inbx awaiting buy signal ...inbx awaiting buy signal
2022-05-02 13:58:32	STANFORD TOLER	inbx for a limited time we are opening our trading chatroom to the public ...inbx for a limited time we are opening our trading chatroom to the public
2022-05-02 13:11:49	REAL-TIME ALERTS	inbx for a limited time we are opening our trading chatroom to the public ...inbx for a limited time we are opening our trading chatroom to the public
2022-04-28 11:53:00	STOCK RESEARCH BOT	inhibrx incs quarterly revenue growth rate yoy of 220 ranked 3002 out of 5722 companies in our database ...inhibrx incs quarterly revenue growth rate yoy of 220 ranked 3002 out of 5722 companies in our database
2022-04-20 08:07:58	SHORTALGO	inbx awaiting short signal ...inbx awaiting short signal
2022-04-11 15:19:44	PRICETARGET.IO	inbx price target update reiterated by jmp securitiesprice target 40day quotechange 199 558tar ... inbx price target update reiterated by jmp securitiesprice target 40day quotechange 199 558tar
2022-04-07 16:17:08	FLASH ALERT	inbx 15s delayed filed sec form 4 chief scientific officer eckelman brendan p disposed 400 of common stock ...inbx 15s delayed filed sec form 4 chief scientific officer eckelman brendan p disposed 400 of common stock
2022-03-30 10:55:44	MONICA	inbx nasdaq stock rating changed to sell inhibrx inc ...inbx nasdaq stock rating changed to sell inhibrx inc
2022-03-29 11:19:07	EAGLE INVESTOR	rt tales5trade inbx global trading community for stocks options and crypto ...rt tales5trade inbx global trading community for stocks options and crypto
2022-03-29 11:18:59	EAGLE INVESTOR	rt tales5trade inbx global trading community for stocks options and crypto ...rt tales5trade inbx global trading community for stocks options and crypto
2022-03-29 11:18:34	EAGLE INVESTOR	inbx if you really want to make huge profits on trading then check out this chat ...inbx if you really want to make huge profits on trading then check out this chat
2022-03-25 11:31:26	FRED JACKSON	inbx join free today for a 10day trial utilizing our stock amp option alerts advisor experience technology mar ...inbx join free today for a 10day trial utilizing our stock amp option alerts advisor experience technology mar
2022-03-25 10:30:22	TRADE TALEZ	inbx global trading community for stocks options and crypto ...inbx global trading community for stocks options and crypto
2022-03-21 11:00:50	TRADE TALEZ	inbx global trading community for stocks options and crypto ...inbx global trading community for stocks options and crypto

[ [ Advertencia de riesgo ] ]

Por favor, recuerda que el Trading es una actividad que pone en riesgo tu dinero y antes de hacerlo debes entender y aceptar los riesgos que eso supone. TradingCero.com no ofrece recomendaciones sobre Inversión ni sobre compra o venta de acciones ni de ningún activo financiero.

TradingCero.com es una web que ofrece información sobre los mercados financieros y Criptodivisas - información de la que no nos responsabilizamos si tuviera algún error - además de publicar cursos de Trading que nos parezcan de calidad e interesantes para nuestros lectores. TODA la información que compartimos así como las sesiones de TRADING que hacemos en nuestro CANAL DE YOUTUBE es SÓLO con FINES EDUCATIVOS.

Es posible que la información mostrada en la Web de TradingCero.com y en el Escáner de Acciones Americanas contenga errores de los que no nos responsabilizamos. Usamos fuentes de información de distintos proveedores por lo que no nos podemos hacer responsables de los errores contenidos en dicha información. Si ves algún error en esta web o en los datos que muestra, por favor, escríbemos un email a pablo@tradingcero.com y lo corregiremos lo antes posible.

TradingCero.com forma parte del programa de afiliados de la Escuela de Trading Tradenet.com y como tal, no nos podemos responsabilizar de los errores o problemas incluídos en sus paquetes formativos y/o servicios profesionales que ofrezca como Escuela de Trading.

Puedes consultar nuestro aviso legal, política de privacidad y política de cookies cuándo lo desees !